US to distribute millions of test kits in its states

▴ us-distribute-millions-test-kits-states
The U.S. government agreed to purchase 150 million rapid antigen tests for COVID-19 from Abbott in a roughly $750 million deal

The U.S. government will send an "overwhelming majority" of the rapid COVID-19 tests it purchased from Abbott Laboratories last week to governors of states and territories to support school reopenings and other critical tasks, an administration official said at a press briefing.

Other top priorities for the newly purchased tests include daycare centers, first responders, and "critical infrastructure," said Admiral Brett Giroir, assistant secretary for health at the U.S. Department of Health and Human Services.

The tests will be distributed in collaboration with Abbott beginning in mid-September, Giroir said. Abbott said last week it will ramp up production to around 50 million tests per month by mid-October.

The U.S. government agreed to purchase 150 million rapid antigen tests for COVID-19 from Abbott in a roughly $750 million deal.

The portable tests can deliver results within 15 minutes and will sell for $5. They require no additional equipment and can use a less invasive nasal swab than traditional lab tests.

Antigen tests are cheaper and faster than molecular diagnostic tests, but somewhat more likely to fail to identify positive cases of the virus than lab-based diagnostic tests.

President Donald Trump has repeatedly pushed for schools to reopen, but most of the largest U.S. school districts have said they would start the school year with online classes.

Giroir also said the Centers for Disease Control and Prevention (CDC) still supports testing asymptomatic individuals for COVID-19 who are prioritized by local health officials or in high-risk populations. Last week, the CDC sparked an outcry among many public health officials when it said testing some asymptomatic people may not be necessary.

The United States has conducted 85 million COVID-19 tests so far with a positivity rate of just over 5%, Giroir said. The mean turnaround time is 2.27 days.

Tags : #USA #School #Government #COVID #COVID-testing #Testingkits

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Cipla Eyes Eli Lilly Partnership to Tap Growing Demand for Obesity Drugs in IndiaMay 13, 2024
Setback for Organ Transplantion: First Human to Receive Pig Kidney DiesMay 13, 2024
Why AstraZeneca is Withdrawing the Covid-19 Vaccine Globally: Explained May 13, 2024
Achieving Healthier Lifestyles: Understanding India's New Dietary GuidelinesMay 11, 2024
The Link Between Childhood Sleep and Adult Psychosis: A Critical AnalysisMay 11, 2024
Uncovering Immunization Gaps: Insights into Measles Vaccination Challenges in IndiaMay 11, 2024
Unlocking New Horizons: Gene Therapies for Hearing Loss and BlindnessMay 10, 2024
Kerala Health Alert: West Nile Fever Cases Confirmed in Thrissur, Malappuram, and KozhikodeMay 10, 2024
Managing Health in the Heat: Demand for Medications Surges in IndiaMay 10, 2024
Sudhamukti Ayurvedic Medicine by OJSP: A New Era in Diabetes ManagementMay 10, 2024
The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
Reducing Stigma, One Story at a Time: Media's Role in Mental HealthMay 07, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024